| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |